Updated results of phase I study of senaparib (IMP4297) in Australian patients with advanced solid tumours

The requested reference [87702c0c442157f91752a2d2aea18f51de4da4aa] no longer exists in our database. It has been replaced by the current reference: [9e495dab46c7013708c88b2723ea1098ed48fb74]

Authors
Category Primary study
JournalAnnals of Oncology
Year 2020
This article has no abstract
Epistemonikos ID: df54df997427f4a4d3ab614576033e6f8ed93f3d
First added on: Feb 12, 2025